A bipartisan group of U.S. lawmakers on July 27 issued a formal inquiry on the Food and Drug Administration’s (FDA) regulation of cannabidiol (CBD), a compound derived from the cannabis sativa plant.
House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-Wash.), and ranking member Frank Pallone Jr. (D-N.J.), along with Senate Health, Education, Labor, and Pensions Committee Chair Bernie Sanders (I-Vt.), and ranking member Bill Cassidy (R-La.) issued a bicameral request for information to “subject matter experts and stakeholders.”
